These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9058629)

  • 1. The soluble interleukin-2 receptor as an indicator of clinical evolution in patients with ulcerative colitis.
    Balzano A; Bove A; Leonardi E; Bevilacqua N; Grande G; Ascierto PA; Castello G
    Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):173-7. PubMed ID: 9058629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
    Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
    J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
    Mueller C; Knoflach P; Zielinski CC
    Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma interleukin-18 reflects severity of ulcerative colitis.
    Wiercinska-Drapalo A; Flisiak R; Jaroszewicz J; Prokopowicz D
    World J Gastroenterol; 2005 Jan; 11(4):605-8. PubMed ID: 15641156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma transforming growth factor-beta1 level in inflammatory bowel disease.
    Kiliç ZM; Ayaz S; Ozin Y; Nadir I; Cakal B; Ulker A
    Turk J Gastroenterol; 2009 Sep; 20(3):165-70. PubMed ID: 19821197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution.
    Díaz-Jiménez D; De la Fuente M; Dubois-Camacho K; Landskron G; Fuentes J; Pérez T; González MJ; Simian D; Hermoso MA; Quera R
    BMC Gastroenterol; 2016 Aug; 16(1):103. PubMed ID: 27565556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of interleukin 23 (IL-23) as a non-invasive test of disease severity in patients with ulcerative colitis.
    Youssef T; Saleh SA; Rund A; Montasser I; Mohsen M; Hazem O
    Arab J Gastroenterol; 2018 Sep; 19(3):116-120. PubMed ID: 30268427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis.
    Dalekos GN; Manoussakis MN; Goussia AC; Tsianos EV; Moutsopoulos HM
    Gut; 1993 May; 34(5):658-64. PubMed ID: 8504967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
    Schürmann G; Betzler M; Post S; Herfarth C; Meuer S
    Digestion; 1992; 51(1):51-9. PubMed ID: 1639222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.
    Wine E; Mack DR; Hyams J; Otley AR; Markowitz J; Crandall WV; Leleiko N; Muise AM; Griffiths AM; Turner D
    J Crohns Colitis; 2013 Dec; 7(11):916-22. PubMed ID: 23339932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
    Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
    Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-2 receptor in children with reflux nephropathy.
    Konda R; Sakai K; Ota S; Takeda A; Chida N; Sato H; Orikasa S
    J Urol; 1998 Feb; 159(2):535-9. PubMed ID: 9649287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
    Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.
    Mitsuyama K; Toyonaga A; Sasaki E; Ishida O; Ikeda H; Tsuruta O; Harada K; Tateishi H; Nishiyama T; Tanikawa K
    Gut; 1995 Jan; 36(1):45-9. PubMed ID: 7890234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease.
    Louis E; Belaiche J; van Kemseke C; Franchimont D; de Groote D; Gueenen V; Mary JY
    Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):939-44. PubMed ID: 9391781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum m 30 levels reflects ulcerative colitis activity.
    Aktaş B; Altınbaş A; Başar O; Yılmaz B; Ekiz F; Giniş Z; Oztürk G; Coban S; Tuna Y; Uçar E; Erarslan E; Yüksel O
    Inflamm Bowel Dis; 2013 Oct; 19(11):2400-3. PubMed ID: 23945185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
    Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
    J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc, copper and immunological markers in the circulation of well nourished patients with ulcerative colitis.
    Dalekos GN; Ringstad J; Savaidis I; Seferiadis KI; Tsianos EV
    Eur J Gastroenterol Hepatol; 1998 Apr; 10(4):331-7. PubMed ID: 9855050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Correlation of Fecal Calprotectin and the Clinical Disease Activity Index in Patients With Ulcerative Colitis.
    Amiriani T; Besharat S; Dadjou M; Roshandel G; Mirkarimi H; Salamat F; Joshaghani H
    Gastroenterol Nurs; 2018; 41(3):201-205. PubMed ID: 29847394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.
    Tzivras M; Koussoulas V; Giamarellos-Bourboulis EJ; Tzivras D; Tsaganos T; Koutoukas P; Giamarellou H; Archimandritis A
    World J Gastroenterol; 2006 Jun; 12(21):3416-9. PubMed ID: 16733861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.